Escalating Antimicrobial and Antifungal Resistance: Mechanistic Insights and Natural Product-Based Interventions
TL;DR
The current tendencies in AMR and AFR are discussed, the molecular-based mechanisms are clarified, and the possibility of the natural product-based intervention as alternative or additive treatment is assessed.
Abstract
Background: Antimicrobial resistance (AMR) and antifungal resistance (AFR) have emerged as significant health risks in the world, with recent (2024-2025) data on the growth in resistance of pathogens (Acinetobacter baumannii, Candida aureus, Trichophyton indotineae, etc.) causing treatment failure and mortality. Objective: To discuss the current tendencies in AMR and AFR, clarify the molecular-based mechanisms, and assess the possibility of the natural product-based intervention as alternative or additive treatment. Methods: The recent literature and worldwide surveillance reports were reviewed in the form of a narrative, and the selected topic included resistance epidemiology, molecular pathways (enzymatic degradation, target modification, efflux pumps, biofilms, and gene transfer), and emerging natural therapeutics such as phytochemicals and nanocarrier systems. Results: There was great increase in the number of multidrug resistant bacterial and fungal pathogens, with last-line agent resistance. Natural products like cinnamaldehyde, eugenol and curcumin showed potential antimicrobial effects especially by a synergistic and biofilm disrupting mechanism. Greater bioavailability was increased with the help of advanced delivery systems, but clinical validation is limited. Conclusion: AMR and AFR is an urgent world problem that needs comprehensive measures. Natural products have a good potential in adjunctive solutions, but the standardized clinical validation and regulatory frameworks are the key to successful translation of these solutions into practices.